Related Experiment Videos
Cooling the asphyxiated brain - ready for clinical trials?
1St Michael's Hospital, Division of Child Health, University of Bristol, Southwell Street, BS2 8EG Bristol, UK,
European Journal of Pediatrics
|December 11, 1999
Summary
Therapeutic hypothermia, or cooling, significantly protects newborns from brain damage caused by hypoxia-ischaemia. This neuroprotective method, when initiated after the insult, shows promise with no identified adverse effects in initial infant studies.
Area of Science:
- Neonatal neurology
- Neuroscience
- Therapeutic hypothermia
Background:
- Hypoxia-ischaemia is a major cause of brain injury in newborns.
- Therapeutic hypothermia has demonstrated long-lasting neuroprotection in animal models.
- Concerns exist regarding the impact of additional stress during cooling.
Purpose of the Study:
- To evaluate the neuroprotective effects of therapeutic hypothermia in newborn models of hypoxia-ischaemia.
- To assess the safety and efficacy of cooling in severely asphyxiated infants.
Main Methods:
- Utilized newborn animal models to study hypoxia-ischaemia.
- Applied cooling at 3-6°C for up to 72 hours post-insult.
- Conducted Phase 1 studies on cooling asphyxiated infants.
Main Results:
- Cooling provided long-lasting neuroprotection in animal models.
- Initial studies in infants showed no systemic adverse effects from therapeutic hypothermia.
- Additional stressors may diminish the neuroprotective benefits of hypothermia.
Conclusions:
- Strong evidence supports hypothermia in reducing brain damage following asphyxia.
- Randomized trials are warranted to confirm the efficacy of therapeutic hypothermia in infants.